AssetMark Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.1M | Buy |
|
|||||
|
2025
Q1 | $41.4M | Buy |
|
|||||
|
2024
Q4 | $32.2M | Sell |
|
|||||
|
2024
Q3 | $94.9M | Sell |
|
|||||
|
2024
Q2 | $178M | Sell |
|
|||||
|
2024
Q1 | $160M | Sell |
|
|||||
|
2023
Q4 | $158M | Sell |
|
|||||
|
2023
Q3 | $175M | Sell |
|
|||||
|
2023
Q2 | $180M | Sell |
|
|||||
|
2023
Q1 | $170M | Buy |
|
|||||
|
2022
Q4 | $116M | Buy |
|
|||||
|
2022
Q3 | $112M | Buy |
|
|||||
|
2022
Q2 | $2.14M | Buy |
|
|||||
|
2022
Q1 | $1.27M | Buy |
|
|||||
|
2021
Q4 | $400K | Buy |
|
|||||
|
2021
Q3 | $20K | Sell |
|
|||||
|
2021
Q2 | $30K | Sell |
|
|||||
|
2021
Q1 | $36K | Buy |
|
|||||
|
2020
Q4 | $31K | Sell |
|
|||||
|
2020
Q3 | $42K | Sell |
|
|||||
|
2020
Q2 | $90K | Buy |
|
|||||
|
2020
Q1 | $16K | Sell |
|
|||||
|
2019
Q4 | $16K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $567K | Sell |
|
|||||
|
2018
Q2 | $515K | Sell |
|
|||||
|
2018
Q1 | $512K | Sell |
|
|||||
|
2017
Q4 | $2.58M | Buy |
|
|||||
|
2017
Q3 | $7K | Buy |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $5K | Sell |
|
|||||
|
2016
Q3 | $10K | Buy |
|
|||||
|
2016
Q2 | $0 | Hold |
|
|||||
|
2016
Q1 | $0 | Sell |
|
|||||
|
2015
Q4 | $6K | Buy |
|
|||||
|
2015
Q3 | $1K | Buy |
|